John R. Fozard

13.4k total citations · 4 hit papers
165 papers, 11.1k citations indexed

About

John R. Fozard is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, John R. Fozard has authored 165 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Molecular Biology, 55 papers in Cellular and Molecular Neuroscience and 48 papers in Physiology. Recurrent topics in John R. Fozard's work include Neurotransmitter Receptor Influence on Behavior (39 papers), Receptor Mechanisms and Signaling (35 papers) and Asthma and respiratory diseases (27 papers). John R. Fozard is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (39 papers), Receptor Mechanisms and Signaling (35 papers) and Asthma and respiratory diseases (27 papers). John R. Fozard collaborates with scholars based in Switzerland, United Kingdom and France. John R. Fozard's co-authors include Derek N. Middlemiss, P.P.A. Humphrey, P.R. Saxena, Ewan J. Mylecharane, David E. Clarke, Daniël Hoyer, Graeme R. Martin, Paul Hartig, Mark D. Tricklebank and G. Engel and has published in prestigious journals such as Science, Biochemical and Biophysical Research Communications and Pharmacological Reviews.

In The Last Decade

John R. Fozard

162 papers receiving 10.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

1994 2.6k citations Daniël Hoyer, David E. Clarke et al. Pharmacological Reviews profile →
Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine

1986 1.0k citations G. Engel, John R. Fozard et al. profile →
8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site

1983 764 citations John R. Fozard et al. European Journal of Pharmacology profile →
The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-Propylamino) tetralin in the rat

1984 624 citations John R. Fozard et al. European Journal of Pharmacology profile →

Peers

Countries citing papers authored by John R. Fozard

Since Specialization

Citations

This map shows the geographic impact of John R. Fozard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Fozard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Fozard more than expected).

Fields of papers citing papers by John R. Fozard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Fozard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Fozard. The network helps show where John R. Fozard may publish in the future.

Co-authorship network of co-authors of John R. Fozard

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Fozard. A scholar is included among the top collaborators of John R. Fozard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Fozard. John R. Fozard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In vivopharmacological evaluation of compound 48/80‐induced airways oedema by MRI 2008 ·British Journal of Pharmacology ·Harry Karmouty‐Quintana, (unknown), Catherine Cannet, Stefan Zurbruegg, John R. Fozard, Clive Page, Nicolau Beckmann	8
2	Bleomycin‐induced lung injury assessed noninvasively and in spontaneously breathing rats by proton MRI 2007 ·Journal of Magnetic Resonance Imaging ·Harry Karmouty‐Quintana, Catherine Cannet, Stefan Zurbruegg, (unknown), John R. Fozard, Clive Page, Nicolau Beckmann	33
3	Identification with MRI of the pleura as a major site of the acute inflammatory effects induced by ovalbumin and endotoxin challenge in the airways of the rat 2006 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Harry Karmouty‐Quintana, Catherine Cannet, (unknown), Stefan Zurbruegg, Rosemary Sugar, Lazzaro Mazzoni, Clive Page, John R. Fozard, Nicolau Beckmann	17
4	In Vitro and in Vivo Pharmacological Characterization of 5-[(R)-2-(5,6-Diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1 H-quinolin-2-one (Indacaterol), a Novel Inhaled β2 Adrenoceptor Agonist with a 24-h Duration of Action 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Cliff H. Battram, Steven J. Charlton, Bernard Cuenoud, Mark R. Dowling, Robin A. Fairhurst, (unknown), John R. Fozard, Juliet Leighton-Davies, Christine A. Lewis, (unknown), Robert Turner, Alexandre Trifilieff	128
5	Role of endogenous adenosine in the acute and late response to allergen challenge in actively sensitized Brown Norway rats 2003 ·British Journal of Pharmacology ·(unknown), Lazzaro Mazzoni, John R. Fozard	6
6	Effects of a mitogen-activated protein kinase inhibitor on allergic airways inflammation in the rat studied by magnetic resonance imaging 2003 ·European Journal of Pharmacology ·Bruno Tigani, Franco Di Padova, (unknown), (unknown), Láśzló Révész, John R. Fozard, Nicolau Beckmann	11
7	Pulmonary Inflammation Monitored Noninvasively by MRI in Freely Breathing Rats 2002 ·Biochemical and Biophysical Research Communications ·Bruno Tigani, (unknown), Rosemary Sugar, Alan D. Jackson, John R. Fozard, Nicolau Beckmann	42
8	Airway hyperresponsiveness to adenosine induced by lipopolysaccharide in Brown Norway rats 2002 ·British Journal of Pharmacology ·Bruno Tigani, Jason Hannon, (unknown), Lazzaro Mazzoni, John R. Fozard	9
9	Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat 2002 ·European Journal of Pharmacology ·John R. Fozard, (unknown), (unknown), Bruno Tigani, Lazzaro Mazzoni	93
10	KATPChannel Openers for the Treatment of Airways Hyperreactivity 1999 ·Pulmonary Pharmacology & Therapeutics ·(unknown), John R. Fozard	16
11	SCA 40: studies of the relaxant effects on cryopreserved human airway and vascular smooth muscle 1997 ·British Journal of Pharmacology ·Else Müller‐Schweinitzer, John R. Fozard	14
12	International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). breakdown → 1994 ·Pharmacological Reviews ·Daniël Hoyer, David E. Clarke, John R. Fozard, Paul Hartig, Graeme R. Martin, Ewan J. Mylecharane, P.R. Saxena, P.P.A. Humphrey	2558
13	Adenosine A₃ receptors¹ mediate hypotension in the angiotensin II‐supported circulation of the pithed rat 1993 ·British Journal of Pharmacology ·John R. Fozard, Alan Carruthers	103
14	The novel 5‐HT_1A receptor antagonist, SDZ 216–525, decreases 5‐HT release in rat hippocampus in vivo 1993 ·British Journal of Pharmacology ·Trevor Sharp, Richard McQuade, John R. Fozard, Daniël Hoyer	20
15	Haemodynamic responses to N^G‐monomethyl‐l‐arginine in spontaneously hypertensive and normotensive Wistar‐Kyoto rats 1991 ·British Journal of Pharmacology ·John R. Fozard, Marie‐Louise Part	52
16	MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease 1989 ·Journal of Neural Transmission - Parkinsons Disease and Dementia Section ·Monique Zreika, John R. Fozard, Mark W. Dudley, (unknown), Ian A. McDonald, Michael G. Palfreyman	24
17	Mechanism of the attenuation of naloxone induced jumping behavior in morphine dependent mice by 5 ht 1 receptor agonists 1988 ·British Journal of Pharmacology ·Heiner K. Berthold, John R. Fozard, G. Engel, E. Flückiger	1
18	Comparison between the cardiovascular effects of 8‐hydroxy‐2‐(di‐n‐propylamino) tetralin (8‐OH‐DPAT) and clonidine in the conscious sino‐aortic denervated rat 1988 ·Journal of Autonomic Pharmacology ·Margaret A. Petty, (unknown), G. F. Di Francesco, John R. Fozard	5
19	Selective blockade of presynaptic tryptamine receptors by (-)-cocaine and (+)-cocaine [proceedings]. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·John R. Fozard, (unknown), (unknown)	1
20	Proceedings: Stimulant effects of 5-hydroxytryptamine on cardiac sympathetic nerves. 1975 ·British Journal of Pharmacology ·John R. Fozard, Gabriel Mwaluko	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact